Lonza Group stock gains 1.46 percent on SIX after H1 growth update
Published on 09/25/2026 at 12:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group stock (ISIN CH0013841017) gained 1.45959 percent on the SIX Swiss Exchange to CHF 570.00 at the official close on September 24, 2026. The move came as the contract development and manufacturing organization continued to show double-digit growth in the first half of 2026.
H1 growth supports the valuation
According to Quartr, Lonza reported H1 2026 sales growth of 16 percent at constant exchange rates and a CORE EBITDA margin of 34.8 percent. The company also upgraded its full-year 2026 outlook, giving the recent share performance a direct operating reference.
The segment picture adds differentiation. Advanced Synthesis grew 28 percent in H1 2026, while Integrated Biologics was growing at 10 percent as new capacity came online, according to Quartr. Management expects Advanced Synthesis growth to normalize in the second half, making capacity execution and margin durability key variables for the next update.
Analysts see further upside
Marketscreener lists an average target price of CHF 688.17 from 24 analysts and an average Buy recommendation. Against the SIX close of CHF 570.00 on September 24, 2026, that target stands CHF 118.17 higher, or 20.73 percent above the share price.
The valuation already reflects a demanding operating profile. Quartr reports that Lonza expects Advanced Synthesis margins to stabilize around 40 percent after the 48 percent H1 2026 level, while capital expenditure is expected to normalize to 14 percent to 19 percent of sales. That comparison separates current earnings strength from the margin level management considers sustainable.
Stock stays below yearly high
Lonza shares traded between CHF 559.20 and CHF 573.80 on September 24, 2026, with 114,643 shares changing hands. The CHF 570.00 close was CHF 27.80 below the 52-week high of CHF 597.80 cited by finanzen.ch for August 25, 2026, a gap of 4.65 percent.
Market capitalization stood at CHF 39.25 billion as of September 24, 2026. The combination of a 1.45959 percent daily gain, 16 percent H1 sales growth and a 34.8 percent CORE EBITDA margin leaves execution on capacity and the upgraded 2026 outlook as the central valuation test.
Lonza Group stock at a glance
- Company: Lonza Group AG
- ISIN: CH0013841017
- Ticker: LONN
- Trading venue: SIX Swiss Exchange
- Price (as of September 24, 2026): CHF 570.00, official close
- Market capitalization: CHF 39.25 billion (as of September 24, 2026)
- 52-week range: CHF 559.20-CHF 597.80
- Sector / Industry: Biotechnology and chemicals
- Index membership: SMI, SPI and SLI
